Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing.
Frequently asked questions
What is the Virtus LifeSci Biotech Products ETF (BBP) expense ratio?
The Virtus LifeSci Biotech Products ETF funds expense ratio is 0.79%.
What is Virtus LifeSci Biotech Products ETF (BBP) current stock price?
As of the latest data, Virtus LifeSci Biotech Products ETF stock price is $101.90, with a previous close of $102.07. Virtus LifeSci Biotech Products ETF lost -$0.17 in the last trading session, representing a -0.17% loss.
Does Virtus LifeSci Biotech Products ETF (BBP) pay dividends?
No. Virtus LifeSci Biotech Products ETF does not pay a dividend.
